Home›Trial›NCT06332014
🔬NCT06332014Phase 4ACTIVE NOT RECRUITING

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Study Summary

The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.

Conditions
Osteoporosis
Interventions / Drugs
Prolia
View on ClinicalTrials.gov ↗
Sponsor
AMGN
Amgen Inc
Biologics
F33/100
Study Details
Enrollment102 participants
Primary Completion—
Lead SponsorAmgen
Data Retrieved2026-04-13 18:29:34.157435+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.